
Bernard I. Dentz
Examiner (ID: 378)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1201, 1622, 5333, 1203, 1625, 2899 |
| Total Applications | 3129 |
| Issued Applications | 2568 |
| Pending Applications | 93 |
| Abandoned Applications | 468 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6225802
[patent_doc_number] => 20020004603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-10
[patent_title] => 'Process for the preparation of maleic anhydride'
[patent_app_type] => new
[patent_app_number] => 09/901686
[patent_app_country] => US
[patent_app_date] => 2001-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9765
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20020004603.pdf
[firstpage_image] =>[orig_patent_app_number] => 09901686
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/901686 | Process for the preparation of maleic anhydride | Jul 10, 2001 | Issued |
Array
(
[id] => 7645431
[patent_doc_number] => 06472539
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-29
[patent_title] => 'Production process of diphosphine oxide and diphosphonate'
[patent_app_type] => B1
[patent_app_number] => 09/899207
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5067
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/472/06472539.pdf
[firstpage_image] =>[orig_patent_app_number] => 09899207
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/899207 | Production process of diphosphine oxide and diphosphonate | Jul 5, 2001 | Issued |
Array
(
[id] => 1261063
[patent_doc_number] => 06664043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-12-16
[patent_title] => 'Acridinium ester labels having hydrophilic modifiers'
[patent_app_type] => B2
[patent_app_number] => 09/898381
[patent_app_country] => US
[patent_app_date] => 2001-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10215
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/664/06664043.pdf
[firstpage_image] =>[orig_patent_app_number] => 09898381
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/898381 | Acridinium ester labels having hydrophilic modifiers | Jul 2, 2001 | Issued |
Array
(
[id] => 6243596
[patent_doc_number] => 20020045764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Tubulin binding compounds (COBRA)'
[patent_app_type] => new
[patent_app_number] => 09/893802
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12163
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045764.pdf
[firstpage_image] =>[orig_patent_app_number] => 09893802
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/893802 | Tubulin binding compounds (COBRA) | Jun 27, 2001 | Abandoned |
Array
(
[id] => 1239881
[patent_doc_number] => 06686310
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-03
[patent_title] => 'High surface area sol-gel route prepared hydrogenation catalysts'
[patent_app_type] => B1
[patent_app_number] => 09/869631
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7409
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/686/06686310.pdf
[firstpage_image] =>[orig_patent_app_number] => 09869631
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/869631 | High surface area sol-gel route prepared hydrogenation catalysts | Jun 27, 2001 | Issued |
Array
(
[id] => 6210223
[patent_doc_number] => 20020072604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => 'Melanocortin receptor ligands'
[patent_app_type] => new
[patent_app_number] => 09/891026
[patent_app_country] => US
[patent_app_date] => 2001-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21623
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20020072604.pdf
[firstpage_image] =>[orig_patent_app_number] => 09891026
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/891026 | Melanocortin receptor ligands | Jun 24, 2001 | Abandoned |
Array
(
[id] => 6345363
[patent_doc_number] => 20020035277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Method for the preparation of citalopram'
[patent_app_type] => new
[patent_app_number] => 09/891874
[patent_app_country] => US
[patent_app_date] => 2001-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4606
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035277.pdf
[firstpage_image] =>[orig_patent_app_number] => 09891874
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/891874 | Method for the preparation of citalopram | Jun 24, 2001 | Issued |
Array
(
[id] => 979111
[patent_doc_number] => 06930115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-16
[patent_title] => 'Antitumor effect potentiators'
[patent_app_type] => utility
[patent_app_number] => 10/311928
[patent_app_country] => US
[patent_app_date] => 2001-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12506
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/930/06930115.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311928
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311928 | Antitumor effect potentiators | Jun 21, 2001 | Issued |
Array
(
[id] => 1535180
[patent_doc_number] => 06489364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-03
[patent_title] => 'Antiviral protease inhibitors'
[patent_app_type] => B2
[patent_app_number] => 09/887758
[patent_app_country] => US
[patent_app_date] => 2001-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17411
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489364.pdf
[firstpage_image] =>[orig_patent_app_number] => 09887758
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/887758 | Antiviral protease inhibitors | Jun 20, 2001 | Issued |
Array
(
[id] => 1031193
[patent_doc_number] => 06878746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-12
[patent_title] => 'Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them'
[patent_app_type] => utility
[patent_app_number] => 10/312175
[patent_app_country] => US
[patent_app_date] => 2001-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4303
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/878/06878746.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312175 | Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them | Jun 18, 2001 | Issued |
Array
(
[id] => 6000684
[patent_doc_number] => 20020028829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin'
[patent_app_type] => new
[patent_app_number] => 09/881869
[patent_app_country] => US
[patent_app_date] => 2001-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21274
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028829.pdf
[firstpage_image] =>[orig_patent_app_number] => 09881869
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/881869 | Method of treating glaucoma | Jun 14, 2001 | Issued |
Array
(
[id] => 975671
[patent_doc_number] => 06933304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-23
[patent_title] => 'Heteroarylalkanoic acids as integrin receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 09/881913
[patent_app_country] => US
[patent_app_date] => 2001-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45991
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/933/06933304.pdf
[firstpage_image] =>[orig_patent_app_number] => 09881913
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/881913 | Heteroarylalkanoic acids as integrin receptor antagonists | Jun 14, 2001 | Issued |
Array
(
[id] => 7354475
[patent_doc_number] => 20040048739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Catalyst comprising soluble polymer and polymino acid'
[patent_app_type] => new
[patent_app_number] => 10/296643
[patent_app_country] => US
[patent_app_date] => 2003-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7576
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048739.pdf
[firstpage_image] =>[orig_patent_app_number] => 10296643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/296643 | Process using catalyst comprising soluble polymer and polymino acid | May 31, 2001 | Issued |
Array
(
[id] => 1486170
[patent_doc_number] => 06365747
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Method for the preparation of citalopram'
[patent_app_type] => B1
[patent_app_number] => 09/830109
[patent_app_country] => US
[patent_app_date] => 2001-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6023
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365747.pdf
[firstpage_image] =>[orig_patent_app_number] => 09830109
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/830109 | Method for the preparation of citalopram | May 31, 2001 | Issued |
Array
(
[id] => 6684241
[patent_doc_number] => 20030120105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Process for the preparation of cyclopropyl carboxylic acid esters and derivatives'
[patent_app_type] => new
[patent_app_number] => 10/275547
[patent_app_country] => US
[patent_app_date] => 2002-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3598
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20030120105.pdf
[firstpage_image] =>[orig_patent_app_number] => 10275547
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/275547 | Process for the preparation of cyclopropyl carboxylic acid esters and derivatives | May 30, 2001 | Issued |
Array
(
[id] => 1393363
[patent_doc_number] => 06545013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-04-08
[patent_title] => '2,7-naphthyridine derivatives'
[patent_app_type] => B2
[patent_app_number] => 09/867016
[patent_app_country] => US
[patent_app_date] => 2001-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35110
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/545/06545013.pdf
[firstpage_image] =>[orig_patent_app_number] => 09867016
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/867016 | 2,7-naphthyridine derivatives | May 28, 2001 | Issued |
Array
(
[id] => 1470918
[patent_doc_number] => 06407266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-06-18
[patent_title] => 'Continuous process for the manufacture of anhydro sugar alcohols and reactor useful therefor'
[patent_app_type] => B2
[patent_app_number] => 09/864466
[patent_app_country] => US
[patent_app_date] => 2001-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2870
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407266.pdf
[firstpage_image] =>[orig_patent_app_number] => 09864466
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/864466 | Continuous process for the manufacture of anhydro sugar alcohols and reactor useful therefor | May 23, 2001 | Issued |
Array
(
[id] => 6880584
[patent_doc_number] => 20010031871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-18
[patent_title] => 'Method for producing pyridine derivatives'
[patent_app_type] => new
[patent_app_number] => 09/862615
[patent_app_country] => US
[patent_app_date] => 2001-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10190
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20010031871.pdf
[firstpage_image] =>[orig_patent_app_number] => 09862615
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/862615 | Method for producing pyridine derivatives | May 22, 2001 | Issued |
Array
(
[id] => 6142457
[patent_doc_number] => 20020002284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-03
[patent_title] => 'Processes and novel intermediates for 11-oxa prostaglandin synthesis'
[patent_app_type] => new
[patent_app_number] => 09/860772
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7596
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20020002284.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860772
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860772 | Processes and novel intermediates for 11-oxa prostaglandin synthesis | May 17, 2001 | Issued |
Array
(
[id] => 7629585
[patent_doc_number] => 06818771
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-16
[patent_title] => 'Process for the production of a naphthyridine carboxylic acid derivative (methanesulfonate sesquihydrate)'
[patent_app_type] => B1
[patent_app_number] => 09/787256
[patent_app_country] => US
[patent_app_date] => 2001-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1224
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/818/06818771.pdf
[firstpage_image] =>[orig_patent_app_number] => 09787256
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/787256 | Process for the production of a naphthyridine carboxylic acid derivative (methanesulfonate sesquihydrate) | May 15, 2001 | Issued |